Literature DB >> 9062998

A mouse model of human familial adenomatous polyposis.

K Yang1, W Edelmann, K Fan, K Lau, V R Kolli, R Fodde, P M Khan, R Kucherlapati, M Lipkin.   

Abstract

In an effort to generate a good mouse model for human colorectal cancer, we generated mice which carry a mutation in the adenomatous polyposis coli (Apc) gene. Mice which are heterozygous for the mutation, designated Apc1638, develop colonic polyps and tumors of the small intestine. Neoplasms were found in 96% of animals studied, and they included adenomas, adenocarcinomas, and polypoid hyperplasias. The mice developed an average of 3.3 tumors, with the highest number in duodenum, followed by jejunum, stomach, ileum, and colon. Focal areas of dysplasias were observed in the colonic mucosa in 50% of mice which were 10 months old or older. These results suggest that mice carrying the Apc1638 mutation can serve as a good model to study the initiation, progression, and inhibition of gastrointestinal tumors.

Entities:  

Mesh:

Year:  1997        PMID: 9062998

Source DB:  PubMed          Journal:  J Exp Zool        ISSN: 0022-104X


  20 in total

1.  Update of preclinical and human studies of calcium and colon cancer prevention.

Authors:  Martin Lipkin
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 2.  An intermittent approach for cancer chemoprevention.

Authors:  Xiangwei Wu; Scott M Lippman
Journal:  Nat Rev Cancer       Date:  2011-11-10       Impact factor: 60.716

3.  Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.

Authors:  Ling Zhang; Xiaoyang Ren; Eckhard Alt; Xiaowen Bai; Shaoyi Huang; Zhengming Xu; Patrick M Lynch; Mary P Moyer; Xian-Feng Wen; Xiangwei Wu
Journal:  Nature       Date:  2010-03-28       Impact factor: 49.962

4.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

5.  Altered dynamics of intestinal cell maturation in Apc1638N/+ mice.

Authors:  Donghai Wang; Rossanna C Pezo; Georgia Corner; Cristina Sison; Martin L Lesser; Shailesh M Shenoy; John M Mariadason; Robert H Singer; Leonard H Augenlicht
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

6.  APC-dependent suppression of colon carcinogenesis by PPARgamma.

Authors:  Geoffrey D Girnun; Wendy M Smith; Stavit Drori; Pasha Sarraf; Elisabetta Mueller; Charis Eng; Prashant Nambiar; Daniel W Rosenberg; Roderick T Bronson; Winfried Edelmann; Raju Kucherlapati; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

7.  Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.

Authors:  Patricia Parsons-Wingerter; Ian M Kasman; Scott Norberg; Anette Magnussen; Sara Zanivan; Alberto Rissone; Peter Baluk; Cecile J Favre; Ursula Jeffry; Richard Murray; Donald M McDonald
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

8.  Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele.

Authors:  Theresa P Pretlow; Winfried Edelmann; Raju Kucherlapati; Thomas G Pretlow; Leonard H Augenlicht
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression.

Authors:  Melanie Kucherlapati; Kan Yang; Mari Kuraguchi; Jie Zhao; Maria Lia; Joerg Heyer; Michael F Kane; Kunhua Fan; Robert Russell; Anthony M C Brown; Burkhard Kneitz; Winfried Edelmann; Richard D Kolodner; Martin Lipkin; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

10.  Gastrointestinal hyperplasia with altered expression of DNA polymerase beta.

Authors:  Katsuhiko Yoshizawa; Elena Jelezcova; Ashley R Brown; Julie F Foley; Abraham Nyska; Xiangli Cui; Lorne J Hofseth; Robert M Maronpot; Samuel H Wilson; Antonia R Sepulveda; Robert W Sobol
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.